Eli Lilly pauses study of COVID-19 antibody like one Trump received over safety concern
WASHINGTON (AP) -- Independent monitors have paused enrollment in a study testing the COVID-19 antiviral drug remdesivir plus an experimental antibody therapy being developed by El…
